Literature DB >> 7295122

Treatment of bilateral groups I through III retinoblastoma with bilateral radiation.

D H Abramson, R M Ellsworth, P Tretter, J Javitt, F D Kitchin.   

Abstract

Thirty-seven patients with bilateral retinoblastoma, groups I, II, and III, were treated with simultaneous bilateral radiation. The median age at diagnosis was 4 months. Twenty-two of these patients were examined because of known history of retinoblastoma. Eight of these 22 patients had no evidence of retinoblastoma on at least one examination before the detection of retinoblastoma, and two had bilateral disease present at birth. Of 74 eyes treated, 39 required additional treatment and 11 ultimately were enucleated. Three patients died of metastatic disease. Seven patients subsequently had second nonocular tumors develop that were both in and out of the field of radiation.

Entities:  

Mesh:

Year:  1981        PMID: 7295122     DOI: 10.1001/archopht.1981.03930020635002

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

Review 1.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma.

Authors:  E P Messmer; W Sauerwein; T Heinrich; W Höpping; D Klueter-Reckmann; N Bornfeld; H Sack; M Förster; W Havers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 3.  The diagnosis of retinoblastoma.

Authors:  D H Abramson
Journal:  Bull N Y Acad Med       Date:  1988-05

Review 4.  Current management strategies for intraocular retinoblastoma.

Authors:  Jonathan W Kim; David H Abramson; Ira J Dunkel
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Bilateral retinoblastoma: the prognosis for vision.

Authors:  C Migdal
Journal:  Br J Ophthalmol       Date:  1983-09       Impact factor: 4.638

6.  Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.

Authors:  David H Abramson; Brian P Marr; Scott E Brodie; Ira Dunkel; Sotiria Palioura; Y Pierre Gobin
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

7.  Establishment of the relationship between tumor size and range of histological involvement to evaluate the rationality of current retinoblastoma management.

Authors:  Jianhua Yan; Hao Zhang; Yongping Li
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

8.  Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.

Authors:  Jasmine H Francis; Nelli Roosipu; Ariana M Levin; Scott E Brodie; Ira J Dunkel; Y Pierre Gobin; David H Abramson
Journal:  Neoplasia       Date:  2018-06-22       Impact factor: 5.715

9.  Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy).

Authors:  David H Abramson; Brian P Marr; Jasmine H Francis; Ira J Dunkel; Armida W M Fabius; Scott E Brodie; Ijah Mondesire-Crump; Y Pierre Gobin
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

10.  Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.

Authors:  David H Abramson; Armida W M Fabius; Reda Issa; Jasmine H Francis; Brian P Marr; Ira J Dunkel; Y Pierre Gobin
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.